Shenkman Capital Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Shenkman Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Shenkman Capital Management from 13F filings

Historical chart of Shenkman Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Shenkman Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2B 2.7M 1171.16
2023-12-31 $3.6B 3.5M 1020.58
2023-09-30 $4.2B 3.7M 1122.46

More positions owned by Shenkman Capital Management

Digitalocean Hldgs Note 12/0 (Principal)
Spdr Ser Tr Bloomberg Sht Te (SJNK)
Enphase Energy Note 3/0 (Principal)
Uber Technologies Note 12/1 (Principal)
Ford Mtr Co Del Note 3/1 (Principal)
Blackline Note 0.125% 8/0 (Principal)
Diamond Offshore Drilli (DO)
Akamai Technologies Note 0.375% 9/0 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Ziff Davis Note 1.750%11/0 (Principal)
Snap Note 0.750% 8/0 (Principal)
On Semiconductor Corp Note 0.500% 3/0 (Principal)
Envestnet Note 2.625%12/0 (Principal)
Exact Sciences Corp Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)

View all positions for Shenkman Capital Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
BlackRock
Braidwell
Lazard Asset Management
Davidson Kempner Capital Management
Readystate Asset Management
Citadel Advisors
Steelhead Partners
Bank of America Corporation
D. E. Shaw & Co
Tenor Capital Management
Bank Of Montreal
FMR
Nuveen Asset Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1